459424-72-7Relevant articles and documents
TRICYCLIC COMPOUNDS AS mPGES-1 INHIBITORS
-
Page/Page column 45, (2012/09/10)
The present invention relates to tricyclic compounds of formula (I) or pharmaceutically acceptable salt thereof as mPGES-1 inhibitors. These compounds are inhibitors of the microsomal prostaglandin E synthase-1 (mPGES-1) enzyme and are therefore useful in the treatment of pain and/or inflammation from a variety of diseases or conditions, such as asthama, osteoarthritis, rheumatoid arthritis, acute or chronic pain and neurodegenerative diseases. (I)
CHROMAN DERIVATIVE AND LIQUID-CRYSTAL COMPOSITION CONTAINING THE COMPOUND
-
, (2008/06/13)
The present invention relates to a liquid crystal compound which has negative dielectric anisotropy and a large absolute value thereof; and a liquid crystal display element which contains the compound as a constituent element and has a negative value of dielectric anisotropy in the vertical alignment mode, IPS, or the like. The liquid-crystal display element has a structure including a pair of substrates and a liquid crystal sandwiched therebetween, and includes at least an alignment control layer, a transparent electrode, and a polarizing plate, in which the liquid crystal includes at least one compound having a partial structure represented by general formula (A): (wherein W1 and W2 each independently represents fluorine, chlorine, -CF3, -CF2H, -OCF3, or -OCF2H) and has negative dielectric anistropy.
Synthesis and mesomorphic properties of some liquid crystals with 2,3,5,6-tetrafluorophenylene unit
Tang,Yang, Yong Gang,Wen
, p. 17 - 24 (2007/10/03)
Nine fluorosubstituted liquid crystals have been synthesized and their mesomorphic properties have been studied by texture observation in a polarizing microscope and confirmed by DSC. They show enantiotropic smectic A and nematic phases. The effect of ter